Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2011

01.10.2011 | Short Research Report

Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China

verfasst von: Xiaoyun Liang, Chenggang Jin, Li Wang, Lian Wei, Goran Tomson, Clas Rehnberg, Rolf Wahlstrom, Max Petzold

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective To assess unnecessary use and cost of antibiotics for inpatient care for children under 14 years of age with pneumonia, and to identify the cost distribution in relation to different socio-economic status. Setting The study was hospital-based and cross-sectional. Method Between July 2007 and June 2008, 226 participants were interviewed in two county hospitals and three township health centers in two counties in rural China. The healthcare facilities provided medical and financial records for all study participants. Appropriateness of antibiotic treatment was assessed, in accordance with guidelines, by a paediatrician from a university teaching hospital, who reviewed all medical records. The cost of unnecessary antibiotics was based on the health facilities’ price lists. Results Unnecessary antibiotic prescriptions occurred in 43% of all patients. The median unnecessary cost of antibiotics was 40 RMB yuan (IQR: 22–100), and this extra cost increased the financial burden for the pneumonia inpatients by 18%. There were no statistically significant differences related to socio-economic categories for unnecessary antibiotics cost (F = 1.43, P = 0.2444). Conclusion Unnecessary prescribing of antibiotics use laid an extra burden on children with pneumonia at inpatient care. Implications for policy and practice might be considered regarding incentives, guidelines and training for health care providers.
Literatur
1.
Zurück zum Zitat Cars O, Hogberg LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, et al. Meeting the challenge of antibiotic resistance. Br Med J. 2008;337:a1438.CrossRef Cars O, Hogberg LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, et al. Meeting the challenge of antibiotic resistance. Br Med J. 2008;337:a1438.CrossRef
2.
Zurück zum Zitat WHO. The world health report 2007: a safer future: global public health security in the 21st century. Geneva: WHO Press; 2007. WHO. The world health report 2007: a safer future: global public health security in the 21st century. Geneva: WHO Press; 2007.
3.
Zurück zum Zitat Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy. 2009;90(1):32–6.PubMedCrossRef Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy. 2009;90(1):32–6.PubMedCrossRef
4.
Zurück zum Zitat Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalised patients at a Chinese university hospital. J Infect. 2003;46(3):161–3.PubMedCrossRef Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalised patients at a Chinese university hospital. J Infect. 2003;46(3):161–3.PubMedCrossRef
5.
Zurück zum Zitat Liu X, Mills A. Evaluating payment mechanisms: how can we measure unnecessary care? Health Policy Plan. 1999;14(4):409–13.PubMedCrossRef Liu X, Mills A. Evaluating payment mechanisms: how can we measure unnecessary care? Health Policy Plan. 1999;14(4):409–13.PubMedCrossRef
6.
Zurück zum Zitat Hopkins A. What do we mean by appropriate health care? Report of a working group prepared for the director of research and development of the NHS management executive. Qual Health Care. 1993;2(2):117–23.CrossRef Hopkins A. What do we mean by appropriate health care? Report of a working group prepared for the director of research and development of the NHS management executive. Qual Health Care. 1993;2(2):117–23.CrossRef
7.
Zurück zum Zitat The Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Chinese Medical Association. Guidelines for management of childhood community acquired pneumonia (for trial implementation). Zhonghua Er Ke Za Zhi. 2007;45(2–3):83–90, 223–230. The Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Chinese Medical Association. Guidelines for management of childhood community acquired pneumonia (for trial implementation). Zhonghua Er Ke Za Zhi. 2007;45(2–3):83–90, 223–230.
8.
Zurück zum Zitat Wagstaff A, O’donnell O, Van doorslaer E, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. Washington: World Bank Publications; 2007. Wagstaff A, O’donnell O, Van doorslaer E, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. Washington: World Bank Publications; 2007.
9.
Zurück zum Zitat Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 1994;34(4):300–5.PubMed Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 1994;34(4):300–5.PubMed
10.
Zurück zum Zitat Zhang W, Liu X, Wang Y, Chen Y, Huang M, Fan M, et al. Antibiotic use in pulmonology wards of Chinese children’s hospitals: 2002–2006. J Clin Pharm Ther. 2009;34(1):61–5.PubMedCrossRef Zhang W, Liu X, Wang Y, Chen Y, Huang M, Fan M, et al. Antibiotic use in pulmonology wards of Chinese children’s hospitals: 2002–2006. J Clin Pharm Ther. 2009;34(1):61–5.PubMedCrossRef
Metadaten
Titel
Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China
verfasst von
Xiaoyun Liang
Chenggang Jin
Li Wang
Lian Wei
Goran Tomson
Clas Rehnberg
Rolf Wahlstrom
Max Petzold
Publikationsdatum
01.10.2011
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2011
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9535-9

Weitere Artikel der Ausgabe 5/2011

International Journal of Clinical Pharmacy 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.